# Zileuton and Exhaled Nitric Oxide in Asthmatics

> **NCT00575861** · PHASE4 · COMPLETED · sponsor: **Gelb, Arthur F., M.D.** · enrollment: 19 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** zileuton

## Key facts

- **NCT ID:** NCT00575861
- **Lead sponsor:** Gelb, Arthur F., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2007-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575861, "Zileuton and Exhaled Nitric Oxide in Asthmatics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00575861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*